Top compounds associated with response to OR10H5


Feature Type Standardized
Nominal ANOVA
mRNA MGCD-265 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.051 0.2
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.043 0.2
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.063 0.2
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.042 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.063 0.2
mRNA regorafenib CTRPv2 pan-cancer AAC -0.047 0.2
Download CSV